Patients’ own blood stem cells combined with immune suppression have provided effective treatment of Type 1 diabetes in human patients, according to a study published in the Journal of the American Medical Association. From the report:
During a 7- to 36-month follow-up (mean 18.8), 14 [out of 15] patients became insulin-free (1 for 35 months, 4 for at least 21 months, 7 for at least 6 months; and 2 with late response were insulin-free for 1 and 5 months, respectively). Among those, 1 patient resumed insulin use 1 year after AHST…The only acute severe adverse effect was culture-negative bilateral pneumonia in 1 patient and late endocrine dysfunction (hypothyroidism or hypogonadism) in 2 others. There was no mortality.
Conclusions High-dose immunosuppression and AHST were performed with acceptable toxicity in a small number of patients with newly diagnosed type 1 DM. With AHST, beta cell function was increased in all but 1 patient and induced prolonged insulin independence in the majority of the patients.
Repeat after me: Embryonic stem cells offer the best hope…Embryonic stem cells offer the best hope…Embryonic stem cells offer the best hope…Embryonic stem cells offer the best hope…….
YOU MIGHT ALSO LIKE
Lift My Chin, Lord
Lift my chin, Lord,Say to me,“You are not whoYou feared to be,Not Hecate, quite,With howling sound,Torch held…
Letters
Two delightful essays in the March issue, by Nikolas Prassas (“Large Language Poetry,” March 2025) and Gary…
Spring Twilight After Penance
Let’s say you’ve just comeFrom confession. Late sunPours through the budding treesThat mark the brown creek washing Itself…
